Introduction
Methylenetetrahydrofolate reductase (MTHFR) is involved in maintaining folate and homocysteine homeostasis, and deˆciencies of MTHFR are implicated in neurological and vascular diseases. To date, many severe mutations and polymorphisms have been identiˆed in MTHFR gene. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Severe MTHFR deˆcien-cy results in marked hyperhomocysteinemia and homocystinuria. Milder deˆciencies of MTHFR are more common in the general population. Two common genetic polymorphisms in MTHFR, 677CÀT (Ala222Val) and 1298AÀC (Glu429Ala), are nonsynonymous amino acid changes that have been associated with a decreased activity of MTHFR and increased levels of homocysteine. 3, 6, 13) The MTHFR 677CÀT variant allele has also been associated with increased toxicity of methotrexate (MTX), [14] [15] [16] [17] a folic acid antagonist that is widely used to treat cancer and immunosuppressive disorders such as rheumatoid arthritis. Individuals with homozygous 677TT or the heterozygous 677CT genotype present increased risk of side eŠects following MTX therapy as compared with those having the wild type 677CC genotype. 16, [18] [19] [20] Studies on genetic variations in MTHFR would be useful to reduce the trial-and-error dosing and the risk of adverse drug reaction.
In the present study, we analyzed all the exons and exon W intron junctions of the MTHFR gene from 200 Japanese individuals by using denaturing HPLC (DHPLC). Additionally, we identiˆed a novel nonsynonymous SNP of the MTHFR gene located in exon 1.
Materials and Methods
Venous blood was obtained from 200 unrelated healthy Japanese volunteers and patients admitted to Tohoku University Hospital. Written informed consent was obtained from all the blood donors, and the study was approved by the Local Ethics Committee of Tohoku University Hospital and Tohoku Pharmaceutical University. DNA was isolated from K2EDTA-anticoagulated peripheral blood by using QIAamp DNA Mini Kits (Qiagen, Hilden, Germany) in accordance with the manufacturer's instructions. Table 1 lists the primer pairs that were used to amplify all exons and exon W intron boundaries of the MTHFR. These primers were designed based on the genomic sequence reported in GenBank (AY338232). Amplicons were generated with the AmpliTaq Gold PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The thermal proˆle consisted of denaturation at 959 C for 10 min, followed by 35-40 cycles of denaturation at 959 C for 30 s, annealing at 609 C for 30 s, extension at 729 C for 30 s, and aˆnal extension at 729 C for 7 min. Heteroduplexes were then generated by means of a thermal cycler as follows: 959 C for 1 min; 959 C, reducing at 1.59 C per 1 min, for 47 cycles.
The PCR products were denatured using the DHPLC system, WAVE } (Transgenomic Inc., Omaha, NE, USA). Unpuriˆed PCR samples (5 mL) were separated on a heated C18 reverse phase column (DNASep } ) using 0.1 M triethylammonium acetate (TEAA) in water and 0.1 M TEAA in 25z acetonitrile at a ‰ow rate of 0.9 mL W min. The software provided with the instrument selected the temperature for the heteroduplex separation in the heterozygous MTHFR fragment. Table 1 summarizes the DHPLC running conditions for each amplicon. The linear acetonitrile gradient was adjusted so that the retention time of the DNA peaks was 4-5 minutes.
Both the strands of samples with variants that were detected using DHPLC were analyzed with a CEQ8000 } automated DNA sequencer (Beckman-Coulter Inc., Fullerton, CA, USA). We sequenced the PCR products by the ‰uorescent dideoxy termination sequencing using the DTCS DNA Sequencing Kit (Beckman-Coulter Inc.) in accordance with the manufacturer's instructions.
For the haplotype analysis of MTHFR variant alleles, the PCR products including fragments from exon 1 to exon 4 of the MTHFR genes were subcloned into a pCR } XL-TOPO } vector (Invitrogen Co., CA, USA). The clones inserted into the MTHFR fragments were sequenced using a CEQ8000 } automated DNA sequencer.
Results and Discussion
We found the following novel SNP: SNP: 050611Hiratsuka06; GENE NAME: MTHFR; ACCESSION NUMBER: AY338232; LENGTH: 25 bases; 5?-CATGAGAGACTCC W TGGGAGAAGAT-GA-3?.
The DHPLC analysis of the MTHFR gene (11 exons) in the 200 DNA samples from Japanese individuals revealed chromatographic proˆles that were distinct from the wild type in exon 1. We tested the speciˆcity of DHPLC in detecting the variant allele in the exon by comparing the results with those of direct sequencing. The DHPLC chromatograms and the electrophoretograms of the novel SNPs are shown in Figs. 1 and 2 , respectively. The SNP in exon 1 was 148CÀT resulting in an amino acid change of Arg46Trp. Haplotype analysis indicated that other SNPs did not exist in the same allele of the MTHFR gene (data not shown). Among the 200 individuals, one was heterozygous for the 148CÀT SNP, suggesting that the allele frequency was 0.0025 in the Japanese population. The sequences for each sample were obtained from at least two diŠerent PCR ampliˆ-cations.
The novel SNP 148CÀT is located in exon 1 of the MTHFR gene and results in amino acid substitution. The N-terminal domain of MTHFR contains the ‰avin binding site and residues necessary to bind a folate substrate and catalyze its reduction. Furthermore, Arg46 is conserved in the MTHFR gene in humans, Escherichia coli, and Salmonella typhimurium.
1) Thus, A Novel SNP in MTHFR Gene SNP37 (389) the amino acid substitution is expected to alter the catalytic properties of the MTHFR gene. To date, many severe mutations and polymorphisms have been identiˆed in the MTHFR gene. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Although we could not determine whether the SNP (148CÀT) found in this study caused a severe mutation leading to hyperhomocysteinemia or a polymorphism which in turn resulted in mild enzyme activity, further studies are being conducted in our laboratory to establish whether the newly identiˆed SNP (148CÀT, Arg46Trp) aŠect the MTHFR function.
In conclusion, we found a novel nonsynonymous SNP (148CÀT) located in exon 1 of MTHFR gene in Japanese individuals. In this mutation, a substitution of Arg to Trp occurs at position 46 in the catalytic domain of MTHFR. The frequency of this mutation in the Japanese population appears to be extremely low (0.25z).
